Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.3.2 was added to the history, and Revision: v3.3.1 appears in the deletions.SummaryDifference0.0%

- Check23 days agoChange DetectedA new revision label v3.3.1 was added and the previous v3.2.0 label removed. No substantive changes to core content or study information are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedRemoved the site-wide notice regarding government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedVersion 113 (2025-05-22) was added to the Record History. This is a routine update to the page's history and does not change the study data or status.SummaryDifference0.0%

- Check74 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference7%

- Check81 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a new release with potential changes behind the scenes but no other substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.